VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 186 filers reported holding VIKING THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.46 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $6,201,193 | +11.7% | 560,180 | +63.6% | 0.04% | +16.1% |
Q2 2023 | $5,549,542 | -38.3% | 342,353 | -36.6% | 0.03% | -49.2% |
Q1 2023 | $8,996,195 | +753.5% | 540,312 | +135.8% | 0.06% | +916.7% |
Q4 2021 | $1,054,000 | +27.8% | 229,119 | +74.4% | 0.01% | 0.0% |
Q3 2021 | $825,000 | -25.7% | 131,404 | -29.1% | 0.01% | -14.3% |
Q2 2021 | $1,111,000 | -49.5% | 185,436 | -46.7% | 0.01% | -53.3% |
Q1 2021 | $2,201,000 | +598.7% | 347,970 | +521.0% | 0.02% | +400.0% |
Q4 2020 | $315,000 | -64.5% | 56,036 | -63.3% | 0.00% | -72.7% |
Q3 2020 | $888,000 | +134.9% | 152,640 | +190.8% | 0.01% | +120.0% |
Q2 2020 | $378,000 | +464.2% | 52,485 | +266.2% | 0.01% | +66.7% |
Q1 2020 | $67,000 | -93.1% | 14,333 | -88.2% | 0.00% | -80.0% |
Q4 2019 | $976,000 | -44.8% | 121,747 | -52.6% | 0.02% | -46.4% |
Q3 2019 | $1,768,000 | -55.9% | 257,040 | -46.8% | 0.03% | -60.0% |
Q2 2019 | $4,010,000 | -9.5% | 483,092 | +8.4% | 0.07% | -1.4% |
Q1 2019 | $4,429,000 | – | 445,569 | – | 0.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Healthcare Value Capital, LLC | 150,000 | $2,613,000 | 6.32% |
Opaleye Management Inc. | 825,000 | $14,371,000 | 3.66% |
Prosight Management, LP | 274,410 | $4,780,000 | 2.66% |
SPHERA FUNDS MANAGEMENT LTD. | 859,727 | $14,976,000 | 1.72% |
KNOTT DAVID M | 236,600 | $4,122,000 | 1.34% |
Sio Capital Management, LLC | 213,252 | $3,715,000 | 1.28% |
NEXTHERA CAPITAL LP | 327,730 | $5,709,000 | 1.09% |
EAM Global Investors LLC | 115,781 | $2,017,000 | 0.82% |
Nicholas Investment Partners, LP | 580,028 | $10,104,000 | 0.81% |
Park West Asset Management LLC | 1,269,107 | $22,108,000 | 0.80% |